Key result
Volanesorsen lowers plasma triglycerides by boosting tissue LPL activity independent of APOE genotype.
Why the study?
Does ApoC-III ASO reduce plasma triglycerides and promote tissue LPL activity in the absence of apoE-mediated clearance?
Does ApoC-III ASO reduce plasma triglycerides and promote tissue LPL activity in the absence of apoE-mediated clearance?
ApoC-III lowering effectively reduces plasma triglycerides by enhancing tissue LPL activity even when apoE-mediated clearance is impaired, providing a mechanistic rationale for its therapeutic use across all APOE genotypes.
Answers are grounded in this paper and cite their sources.
Supports LPL-mediated TG lowering by ApoC-III ASO in animals independent of apoE; leaves open translation to human APOE genotypes.
Elevated plasma triglyceride (TG) levels are an independent risk factor for CVD and all-cause mortality (1). The concentration of plasma TG levels reflects a balance between de novo synthesis in the liver (VLDLs), intestinal absorption of dietary lipids (chylomicrons), lipolysis in the peripheral circulation, and hepatic clearance. TG-rich lipoproteins (TRLs) carry TGs in the blood and are rapidly hydrolyzed by LPL, thereby releasing free FAs for energy production or storage in the surrounding tissues (2-4). The remnant TRLs are subsequently rapidly cleared in the liver by the interaction of apolipoproteins on TRLs with the three main hepatic receptors, heparan sulfate proteoglycan syndecan-1 (SDC1), LDL receptor (LDLR), and LDLR-related protein 1 (LRP1) (5).
No takes yet. Share an insight, caveat, or question.
Ramms et al. (2019) studied Hypertriglyceridemia (n=80). Volanesorsen (ApoC-III ASO) vs. Placebo or Control ASO was evaluated on Percentage change in fasting total APOC3 and triglyceride levels from baseline to end of treatment. ApoC-III ASO (volanesorsen) significantly reduced plasma triglyceride levels by promoting tissue LPL activity independently of apoE-mediated TRL clearance and APOE genotype.
Synapse has enriched 10 related papers. Consider them for comparative context: